Pennsylvania’s final medical marijuana rules include disputed testing change
Pennsylvania regulators approved the final regulations for the state’s medical marijuana market, which was established in 2016.
Pennsylvania regulators approved the final regulations for the state’s medical marijuana market, which was established in 2016.
Four medical marijuana companies in Arkansas are in the crosshairs of a federal civil lawsuit alleging that they conspired to defraud MMJ patients by illegally lying about cannabis potency testing results.
Every state with a legal marijuana program has a unique regulatory framework.
Navigating those different rules while still maintaining quality standards can be a compliance high-wire act for multistate cannabis operators.
Cannabis testing and quality control is no simple feat.
Consider the plant itself: Cannabis contains a super sticky, resin lipid that is harder to work with than coffee, tobacco and most other natural products, said David Vaillencourt, CEO of the GMP Collective consulting firm in Colorado.
While cannabis has enjoyed greater social acceptance in recent years, quality control will be critical to sustaining that growth and winning over the institutions that have yet to embrace a regulated marijuana industry.
A group of marijuana testing labs in Michigan is claiming a large amount of cannabis retail store shelves is rife with mold and yeast.
Massachusetts-based marijuana testing company ProVerde Laboratories shut down its Portland, Maine, location after municipal authorities said it was operating without the necessary local authorizations.
A lack of standards in cannabis testing results is plaguing the industry. Some business owners are shopping around for labs that will give them the results they want to see, while others are sending in adulterated samples. And testing labs are being shuttered by state regulators for allegedly reporting results that don’t match up with audits.
Medical cannabis patients should never have to wonder if their medicine is safe to use.